Genereach Biotechnology Corp operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genereach Biotechnology Corp with three other
pharmaceutical manufacturers in Asia:
Kainos Laboratories, Inc.
sales of 4.67 billion Japanese Yen [US$43.53 million]
Eps Bio Technology Corp
(459.35 million Taiwanese Dollars [US$15.60 million]
OK Biotech Co Ltd
(1.24 billion Taiwanese Dollars [US$42.17 million]
of which 100%
was Ok Biotech Co Ltd).
Genereach Biotechnology Corp reported sales of 365.80 million Taiwanese Dollars (US$12.43 million)
December of 2019.
increase of 95.2%
versus 2018, when the company's sales were 187.42 million Taiwanese Dollars .
Sales at Genereach Biotechnology Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 174%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
829.2% in 2019, from
19.43 million Taiwanese Dollars to 180.50 million Taiwanese Dollars .